跳至主要内容
临床试验/IRCT20230222057495N8
IRCT20230222057495N8招募中Unknown

Bioequivalence study of dapoxetine 60 mg tablet of Sami Saz pharmaceutical company compared to dapoxetine 60 mg sample of Menarini company in England on healthy volunteers

Sami Saz Pharmaceutical Company0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 55 years(—)
性别
All

入选标准

  • Healthy volunteers aged between 18 and 55 years
  • Body mass index less than 30 kg per square meter
  • All candidates must be non-smokers

排除标准

  • Blood pressure less than 90 over 60 mm Hg or more than 140 over 90 mm Hg
  • Consumption of any drugs, alcohol or tobacco products within 2 weeks before receiving the drug

研究者

发起方
Sami Saz Pharmaceutical Company

相似试验

Bioequivalence study of dapoxetine 60 mg tablet | 临床试验